Non-Invasive Prenatal Testing: Is This the Brave New World We Want?
By Alexandra Minna Stern,
The Huffington Post
| 12. 11. 2012
Over the past year, several companies have unveiled non-invasive prenatal tests designed to detect certain genetic conditions by analyzing fragments of fetal DNA contained in a pregnant woman's blood. Unlike the genetic screening currently offered to women early in pregnancy, which is used to calculate the fetus's
risk of developing a particular genetic disorder, non-invasive prenatal testing (NIPT) is diagnostic, and can tell an expectant mother with an extremely high level of accuracy whether or not her fetus actually has trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), or trisomy 13 (Patau syndrome). Endorsed for use among "high-risk" women by the National Society of Genetic Counselors (NSGC), NIPT can obviate the need for amniocentesis or chorionic villus sampling (CVS), both of which are invasive and pose a small risk to the expectant mother and/or fetus.
The comprehensive roll out of NIPT would result
in testing for trisomies among a considerable number of the approximately 5 million American women who become pregnant each year, not just the much smaller sub-set of women who undergo amniocentesis or CVS. NIPT has the potential...
Related Articles
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...
By Rob Stein, NPR | 07.16.2025
Scientists can protect children from being born with certain devastating genetic disorders by creating "three-parent" babies, according to the results of a landmark study released Wednesday.
British researchers used the experimental technique to help families have eight children who appear...
By Jessica Hamzelou, MIT Technology Review | 07.18.2025
This week we heard that eight babies have been born in the UK following an experimental form of IVF that involves DNA from three people. The approach was used to prevent women with genetic mutations from passing mitochondrial diseases to...
By Jessica Hamzelou, MIT Technology Review | 07.16.2025
Eight babies have been born in the UK thanks to a technology that uses DNA from three people: the two biological parents plus a third person who supplies healthy mitochondrial DNA. The babies were born to mothers who carry genes...